NYSE: AGE - AgeX Therapeutics, Inc.

Lønnsomhet i seks måneder: 0%
Utbytte: 0.00%
Sektor: Healthcare

Kampanjeplan AgeX Therapeutics, Inc.

Avansert tidsplan Enkel graf
Financial Markets by TradingView

Om selskapet AgeX Therapeutics, Inc.

AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-related metabolic disorders, such as Type II adult-onset diabetes and obesity; and AGEX-VASC1, a cell-based therapy to restore vascular support in aged ischemic tissues, such as peripheral vascular disease and ischemic heart disease.

flere detaljer
Its lead small molecule drug-based therapeutic candidate for scarless wound repair in discovery is AGEX-iTR1547, a drug-based formulation; and lead biologic candidate for induced tissue regeneration is AGEX-iTR1550 (Renelon), a gene delivery technology. AgeX Therapeutics, Inc. has a research collaboration with the University of California at Irvine to develop cellular therapies to treat neurological disorders and diseases. The company was incorporated in 2017 and is based in Alameda, California.
Legg til i sammenligningslisten
Legg til overvåkningsliste
Legg til portefølje
Legg til prisvarsel

IPO date 2018-11-29
ISIN US00848H1086
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.agexinc.com
Цена ао 11.1
Prisendring per dag: 0% (11.1)
Prisendring per uke: 0% (11.1)
Prisendring per måned: 0% (11.1)
Prisendring over 3 måneder: 0% (11.1)
Prisendring over seks måneder: 0% (11.1)
Prisendring per år: +2 783.12% (0.385)
Prisendring over 3 år: +1 980.99% (0.5334)
Prisendring over 5 år: +635.1% (1.51)
Prisendring over 10 år: 0% (11.1)
Prisendring siden begynnelsen av året: 0% (11.1)
Alle parametere

Undervurdering

Navn Betydning Karakter
P/S 2.98 6
P/BV 0.079 10
P/E 0 0
EV/EBITDA -0.4521 0
Total: 5.13

Effektivitet

Navn Betydning Karakter
ROA, % -123.72 0
ROE, % -270.67 0
Total: 0

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 0 0
Total: 0

Plikt

Navn Betydning Karakter
Debt/EBITDA -0.4441 10
Total: 10

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % -91.65 0
Lønnsomhet Ebitda, % -15.27 0
Lønnsomhet EPS, % 4028.55 10
Total: 2.6
Flere detaljer

Institusjoner Volum Dele, %
Broadwood Capital, Inc. 2997156 7.9
Vanguard Group Inc 701755 1.85
Sigma Planning Corp 286425 0.75
Prescott General Partners LLC 185185 0.49
Bridgeway Capital Management, Inc. 144770 0.38
Geode Capital Management, LLC 140994 0.37
Blackrock Inc. 124301 0.33
Strategic Wealth Investment Group, LLC 97375 0.26
Creative Planning 70700 0.19
Northern Trust Corporation 31533 0.08

ETF Dele, % Lønnsomhet for året, % Utbytte, %
Sprott Uranium Miners ETF 0.42828 343.52 3.27507
Global X Uranium ETF 0.21695 7.84 1.74266



Veileder Stillingstittel Betaling Fødselsår
Ms. Eun-Jae Park CPA Chief Financial Officer 295.29k 1972 (53 år)
Dr. Ivan Labat Chief Information Officer N/A
Ms. Judith Segall Secretary N/A 1953 (72 år)

Adresse: United States, Alameda. CA, 1101 Marina Village Parkway - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.agexinc.com